Scholtz & Company, LLC Edwards Lifesciences Corp Transaction History

Scholtz & Company, LLC

$207 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $4,098 - $5,246	-60 Reduced 0.33%	18,001 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $1.49 Million - $1.94 Million	-18,074 Reduced 50.02%	18,061 $1.35 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $84,164 - $124,806	-973 Reduced 2.62%	36,135 $3.44 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $316,891 - $398,880	-3,108 Reduced 7.73%	37,108 $4.37 Million
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $560,995 - $689,206	-5,274 Reduced 11.59%	40,216 $5.21 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $191,103 - $227,946	-1,857 Reduced 3.92%	45,490 $5.15 Million
Q2 2021 Aug 09, 2021	BUY	$83.84 - $104.76 $347,936 - $434,754	4,150 Added 9.61%	47,347 $4.9 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $37,687 - $43,430	479 Added 1.12%	43,197 $3.61 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $776,546 - $988,203	10,832 Added 33.97%	42,718 $3.9 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $8,801 - $11,454	-131 Reduced 0.41%	31,886 $2.55 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.26 Million - $1.68 Million	21,870 Added 215.53%	32,017 $2.21 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $52,147 - $80,595	995 Added 10.87%	10,147 $1.91 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $7,313 - $8,373	-102 Reduced 1.1%	9,152 $2.14 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $576,661 - $706,703	-9,369 Reduced 50.31%	9,254 $2.04 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $42,083 - $48,629	-755 Reduced 3.9%	18,623 $3.44 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $320,479 - $428,622	-6,692 Reduced 25.67%	19,378 $3.71 Million
Q4 2018 Jan 29, 2019	SELL	$46.41 - $56.94 $525,361 - $644,560	-11,320 Reduced 30.28%	26,070 $3.99 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $145,326 - $184,535	3,180 Added 9.3%	37,390 $6.51 Million
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $4,245 - $5,130	-100 Reduced 0.29%	34,210 $4.98 Million
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $13,016 - $16,607	-350 Reduced 1.01%	34,310 $4.79 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $34,803 - $40,571	-1,030 Reduced 2.89%	34,660 $3.91 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $1.3 Million - $1.39 Million	35,690	35,690 $3.9 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scholtz & Company, LLC with notifications on news.

Account